116 filings
Page 3 of 6
8-K
myorxhh1yjd1r175h
29 Jul 21
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
4:34pm
8-K
vqrm0if4ch3qtc
14 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:52pm
8-K
hyjxls4kp
11 Jun 21
Regulation FD Disclosure
7:10am
8-K
p78xecldh8
2 Jun 21
Other Events
9:16am
8-K
erqhc
27 Apr 21
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
4:05pm
8-K
4w7s1xltlcysd4a4gz05
20 Apr 21
Entry into a Material Definitive Agreement
7:22am
8-K
xfs8 rm0mfzz
16 Feb 21
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
trsc9cqsswuzl2h7q
15 Jan 21
Other Events
4:12pm
8-K
lkgeoofe45bz
17 Dec 20
Other Events
9:06am
8-K
5mp8f0
11 Dec 20
Other Events
8:16am
8-K
x8mlz
7 Dec 20
Regulation FD Disclosure
7:50am
8-K
wdc9157xn q88tx5
4 Nov 20
Regulation FD Disclosure
9:14am
8-K
n9wftmjvv3d4syxkqxx
28 Oct 20
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
8:03am
8-K
c88ewvb u7pab9njw
21 Oct 20
CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies
8:58am
8-K
k70xg6vwj4ylm1h v1cm
27 Jul 20
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
4:35pm
8-K
8b1 dkhwbwmqoy5vuh1y
2 Jul 20
Crispr Therapeutics Announces Proposed Public Offering of Common Shares
4:27pm
8-K
ajb89rw ng5x7vbvo
12 Jun 20
Departure of Directors or Certain Officers
4:28pm
8-K
21poouech1mdi
12 Jun 20
Regulation FD Disclosure
6:04am
8-K
rier502k9x
14 May 20
Regulation FD Disclosure
9:11am
8-K
b56h22xg lmxy
11 May 20
Regulation FD Disclosure
9:12am